2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 215.534 | 0 | 1 | ||
2020 | 0 | 3.089.570 | 303.173 | 1 |
Total number of partners: 9
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 9
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-09-01 | Parallel epigenomic and apoptotic profiling to identify targetable sensitivities in Multiple Myeloma | MM_BH3_CutTag | participant | 215.534 | 2 |
2020-04-01 | Targeted Anti-Cancer Therapies | TACT | participant | 3.089.570 | 9 |